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From a demographic perspective, sex differences in mortality vary markedly with age, with the level of mortality and with the regional pattern of mortality. This has been shownin the study ofmodel life table^.^"" However, a detailed analysis of the patterns' of sex differences by Harvard School of Public Health, Dept. of Population and Intemational Health, 665 Huntington Ave, Boston, MA 021 15, USA.
detailed cause of death has never been completed. There are indications that female mortality can be higher for certain causes of death. In his review of 165 national populations, Preston3 found a consistent excess female mortality for tuberculosis at age 5-29, for certain infectious and parasitic diseases at age 1-14, for certain cancers at age 25-49, frequently for cardiovascular diseases at age 10-39, for influenza-pneumonia-bronchitis at age 5-14, for diarrhoea at age 5-39, for certain chronic diseases at age 10-24, and of course for maternal mortality. Women are also found to have higher risks for the cancers of the genital organs, breast cancers, and are more susceptible to autoimmune diseases. The reasons for this pattern of excess female mortality are not fully understood. In addition, evidence of behavioural factors inducing an excess female mortality among children has been documented, mostly in the Indian Subcontinent.' '-13 This study focuses on sex differences in measles mortality. It grew out of an observation made in rural Senegal, that the case fatality from measles was significantly higher for girls than for b o y~. '~I n this society there was apparently no indication of differences in parental attitudes towards boys and girls, specifically in respect to health maintenance and no indication of sex differences in nutritional status. Therefore, a biological origin was hypothesized for the excess female mortality from measles.
This study investigates the pattern of sex differences in the world in order to substantiate this hypothesis.
DATA AND METHOD

Reference: Model Life Tables
The data used for this analysis were compared to a reference set of model life tables. Model life tables have been developed by demographers to summarize the regularities of age-specific death rates by age and sex in national populations. The classic data set gathered by Coale and Demeny9 has been chosen for this comparison. The Coale and Demeny model life tables are based for the most part on the experience of the same countries as the ones used in this analysis. The model life tables are presented according to clusters of four regional patterns: West (130 life tables), South (22 life tables), East (31 life tables) and North (nine life tables). The West model is the most prevalent in the world and is considered as the most regular. The other patterns are defined by their departure from the West pattern. The model life tables are presented according to a level of mortality, which is defined by the female life expectancy and steps of 2.5 years: level 1 is defined by eo=20 years, level 2 by 22.5 years . . . level 25 by 80 years. The pattern of sex differences in mortality varies according to the level of mortality in each of the regional patterns, and is summarized by an equation linking the life expectancy of males to that of females. Model life tables are given by 5-year age groups, from age O to 85+.
Source of Data
Since 1950, WHO publishes annually data on the causes of death, broken down by sex and age groups of 5 years, from birth to 85+ years, for some 110 countries throughout the world. The countries in question provide the data which come from the national vital registration systems. In addition, WHO maintains a computer file that includes registered deaths and the denominators: that is the population by age and sex for each year and each country for which deaths by cause are available. The original file used for this analysis contained data on measles deaths from 2359 country*years over the 1950-1989 period. However, some of the largest countries of the world were not included in this data set, in particular China, India, Pakistan, Bangladesh, Indonesia, Vietnam, Brazil and most of Tropical Africa.
Sample of Countries
Several countries or years included in the original data set had no record of measles deaths, no breakdown by age, or had large proportions of deaths of unknown age. They were discarded. The final data set included 1500 country*years from 78 countries. However, the geographical coverage of these countries was uneven. The two largest contributions came from developed countries from Europe, North America, Australia and New Zealand (32 countries) and from Latin America (22 countries). Other regions of the world included eight countries from the Middle East and one from South Asia (Sri Lanka) which were grouped together, three countries from Far-East Asia (Japan, Koreaand Hong Kong), and four countries from South-East Asia (Thailand, Philippines, Singapore, Papua New Guinea). In addition, the data set contained data from six Caribbean Islands and three African Islands (Mauritius, Cape Verde, and Sao Tome and Principe).
The final data set covered about 38% of the world population (3.7 billion people in 1970) and 23% of the person-years lived between 1950 and 1989 (150 billion person-years). Furthermore, most of the countries had a relatively low mortality, with a mean of 70 years for female life expectancy in 1970, which corresponded to level 21 in the regional model life tables. Only two countries had a life expectancy below 60 years in 1980-1984 (Egypt, and Sao Tome and Principe), 19% had a life expectancy between 60 and 69 years and 78% had a life expectancy above 70 years. Therefore, the sample was representative only of the recent measles mortality experience in relatively low mortality populations.
For the purpose of regional analysis, the countries were classified according to their regional pattern of mortality. Whenever possible, countries were assigned to the regional pattern defined by Coale and Demenyg or by the United Nations." Other countries were assigned to the 'West' regional pattern.
Morbidity Data
In addition to mortality data, the data on measles incidence published by WHO were also taken into consideration. However, their coverage was of much poorer quality. Only 23 countries consistently reported measles cases by age and sex, covering only 356 country*years during the 1950-1989 period. Even major countries with a good surveillance system of measles, such as the US, did not provide a breakdown of cases by age and sex during this period. Furthermore, most countries provided only an abridged breakdown by age, which was not always compatible from country to country or from year to year. The most common breakdown, which was used for this analysis of morbidity data, was for ages 0-4,5-14,15-44,45+ . Other frequent cutoffs were ages 1, 10,25,65 and 75 years.
Countries and years for which data were available by sex and any age grouping accounted for 13.4 million measles cases, a small proportion of the total number of measles cases occurring during the 1950-1989 period in the world. When restricted to countries providing a breakdown by sex and by the four most frequent age groups (0-4, 5-14, 15-44,45+) , only 17 countries were left, accounting for 4.1 million measles cases. These data were used exclusively to study sex differences in morbidity, not for calculating incidence rates.
Indicators
Three key indicators of measles epidemiology were utilized: the death rate (DR), the incidence rate (INC), and the case fatality ratio (CFR). The death rate was defined as the ratio of deaths to person-years lived; the incidence rate as the ratio of cases to person-years lived (by age and sex) and the case fatality ratio as the ratio of deaths to cases. Only the death rate was computed directly in the WHO sample of 78 countries. Asimple relationship links the death rate to the incidence rate and the case fatality ratio:
Death rate:DR = Deathdperson-years Incidence rate:INC = Cases/person-years Case fatality ratio:CFR = Deathskases Re1ationship:CFR = DRlINC Similarly, three key indicators of sex differences were also used: the female sex ratio (FSR) of each of the three indicators quoted above. The FSR (I00 * female indicator/male indicator) was chosen to bring to the fore the excess female mortality. The calculation of FSR of incidence and case fatality did not require the calculation of incidence and of case fatality. These could be calculated directly from the ratio of the sex ratios of cases to the sex ratio of person-years (incidence) and from the ratio of the sex ratio of deaths to the sex ratio of cases (case fatality). A similar relationship links the sex ratios of the three indicators: The FSR of death rates were calculated for the 5-year age groups, from 0-4,5-9, . . . to 85+. For incidence and case fatality, female sex ratios were computed only for broader age groups: 0-4,5-14,15-44,45-99. A comparison of female sex ratios of death rates between the four FSR(deaths) = female deathdmale FSR(cases) = female caseslmale cases deaths broad age groups was also drawn. A weighted geometric mean (WG-mean) of female sex ratios in the three age groups 0-4,5-14 and 15-44 was calculated to summarize the excess female mortality below age 45 years. A geometric mean was chosen rather than an arithmetic mean to facilitate the merging of several age groups and to permit calculation of the variance. The weights used (0.8624, O. 1229,0.0147) were the inverse of the variance, in order to give more weight to age groups where the measles deaths were most concentrated, e.g. the 0-4 age group. The variances of the logarithm (Varlog) of the estimates were calculated using the standard Taylor series formulae of rates and ratios. In the variance of the logarithm of the case fatality ratio, the (1-CFR) term, of very small value, was considered negligible. The variance of the population was also considered negligible:
RESULTS
Age Pattern
The age pattern of age-specific death rates from measles was very pronounced (Figure 1 ). Death rates declined steadily from age 0-4 to age 45-49 and increased afterwards. At age 85+, measles death rates were as high as at age 15. However, measles death rates were especially high at age 0-4 (166 per million person-years) and at age 5-9 (20 per million person-years). This age pattern is the result of decreasing incidence with age, decreasing case fatality from age O to age 10, and increasing case fatality after age 10, as with most other causes of death from communicable diseases.
Sex Differences
Female sex ratios of measles death rates for all countries and years combined were first compared to 100 ( Figure  2 , Table 1 ). For the data set as a whole, the FSR was higher than 100 from birth until age 45-49 and below 100 after age 50 years. Results were highly statistically significant. The excess female mortality was already noticeable at age 0-4 (+4.2%) and even more pronounced at age 5-14 (+10.9%). A major peak of excess female mortality was visible at age 25-29, with an FSR of 188, that is 88% excess female mortality frommeasles compared to males. In the age group 15-44, the excess female mortality was (Figure 2 , Table 1 ). The excess female mortality was 39% at age 0-4, 43% at age 5-14 and 88% at age 15-44. There was no difference between observed and expected sex ratios after age 45 years. The excess female mortality from measles at age 0-44 was 40% higher than the WG-mean of the expected FSR. The peak of excess female measles mortality noticed at age 25-29 corresponded to a low value Islands have a population of c 1 O00 O00 inhabitants. * = Significantly higher than expected for all causes of death, P c 0.05 ** = Sipificantly higher than 100, P c 0.05.
in Far-East Asia, 4.3% in Latin America and 20.9% in the Middle East. At age 0-4, the excess female mortality ranged from 1.7% to 21.3% in the five regions. There was a marked excess of female mortality from measles in the Middle East, which explained the high value noted for the WGmean. At age 5-14, the pattern of excess female mortality was very consistent throughout the world, including in South-East Asia and in the Islands. The excess ranged from 8.3 to 29.2%. At age 1544, the pattern was less consistent, mostly because the number of deaths was much smaller.
A comparison with expected values was performed for each country with the corresponding regional model and the same life expectancy. Here again, the results were striking. Except in Islands, the FSR was 21% to 55% higher than expected. The highest difference between observed and expected FSR occurred in North America (+55%).
Country Analysis
Most countries followed the pattern described above. However, there were a few exceptions. For instance, two countries had an FSR significantly lower than 100 at age 0-4: Thailand (FSR = 93.9, P = 0.0072) and Sao Tome and Principe (FSR = 49.5, P= 0.0022). One country had an FSR significantly lower at age 5-14 than at age 0-4: Mauritius (FSR 5-14 = 29.2, FSR 0-4 = 224.9, P = 0.0214). Two countries had an FSR significantly lower at age 15-44 than at age 5-14: Philippines (FSR 15-44= 80.3, FSR 5-14 = 1 11.3, P = 0,0098) and Thailand (FSR 1 5 4 4 = 71.2, FSR 5-14 = 105.4, P = 0.0006). There was no country where the FSR at age 45-99 was significantly higher than 100.
A Case Study ìn England and Wales
Since some of the worldwide data can be considered of doubtful quality, a separate analysis was performed for England and Wales. These nations have a long history of maintaining an accurate record of measles cases and measles deaths. Together with Iceland, they reported the highest number of measles cases per capita over the 1950-1989 period. Since July 1837, data on deaths have been published by age and sex in England and Wales. For most of the years after 1837, they are provided by main causes of deaths, among which measles is always present. For the period after 191 1, the data are available on computer, and only this part was used for our analysis. The first 9 years were not considered for the case study, since World War I introduced major disturbances: there was a marked excess of measles deaths among men aged 15-44 in 1915-1919 . This was the sole period during which there was an excess male mortality at those ages. During the 1920-1989 period, 77 357 measles deaths were reported in England and Wales. The sex differences in measles mortality were compared to the exact values of life tables for the same nations.
During the 1920-1989 period, England and Wales also experienced a similar pattern of excess female mortality (Table 3) , although the pattern was less pronounced than in the world as a whole. At age 0-4, the FSR was lower than 100, but it was 13% higher than expected from all causes of death. At age 5-14, the FSR was 101.0, a 35% excess compared to the general pattern of mortality. At age 15-44, the FSR was significantly higher than 100 and 89% higher than expected, a value similar to other countries. However, the excess of female mortality persisted beyond age 45, a pattern different 1957-1959. from other countries. Only at age 75+ were the observed values of FSR equal to the expected values.
Statistical Power Analysis
Since the FSR of death rates had a wide confidence interval, the probability of finding the excess female mortality in a country depended primarily upon the number of deaths recorded in this country. A formal analysis of the statistical power to detect a significant excess female mortality was conducted. The hypothesis to be tested was that the WG-mean of the FSR was significantly higher than 100 with a risk a= 0.05. Empirical values of the FSR and of the distribution of deaths in each age group W,5-14 and 15-44 were utilized for the direct calculation of risk ß. A normal distribution of logarithms of the FSR around the expected value was assumed. The distribution of the FSR was strongly associated with the number of deaths considered (Table 4) . For instance, when less than 100 measles deaths were recorded in a country, the FSR was higher than expected in 11.7% of cases and higher than 100 in 5.6% of cases, whereas corresponding values were lOO% and 75% when at least 10 O00 measles deaths were recorded. There was a steady increase in the proportion of countries where the FSR was higher than expected and where the FSR was higher than 100 with increasing number of deaths.
There was a close correlation between the empirical proportion of countries where the FSR was significantly higher than 100 and the statistical power to prove the hypothesis ( Table 4) . With less than 100 deaths, the power was 5.0% and the empirical value was 5.6%, whereas with more than 100 O00 deaths the power was 99.9% and the empirical value 100.0%. There was no statistical difference between the two distributions of the observed and the expected proportions of countries with FSR significantly higher than 100 01' = 1 30, P = O. 180).
With a power of 90%, the number of measles deaths required to test the hypothesis was 13 046. Only 12 countries met this criteria. Among them, 11 cases had an FSR greater than 100 and nine cases were significant with P < 0.05. The most noticeable exception was the Philippines (Annex 1).
Anal-vsis of Incidence
In theory, excess female mortality could come from ei- (based on 661 O00 measles deaths from 78 countries and 4 100 O00 measles cases from 17 countries).
"WG-mean= weighted geometric mean, age 0 4 4 years. See text for definition.
ther excess incidence or from excess case fatality. Although they covered only a small part of the world experience, the data on incidence seemed to exhibit a consistent pattern of sex differences. Table 5 summarizes the decomposition of sex ratios of the population, the measles cases and the measles deaths and therefore of the sex ratios of mortality, incidence and case fatality. There was a slight deficit of females in measles incidence among children, from age 0-4 (FSR = 97.8) to age 5-14 (FSR = 98.4). The deficit of females became more pronounced at age 15-44 (FSR = 90.0) and at age 45-99 (FSR = 68.4). In the countries for which further breakdown was provided, the FSR of incidence continued to diminish at older ages and was 58.6 at age 65-99. Therefore, the excess female risk shown in the death rates from age O to 44 appeared to be an underestimation of the sex differences in case fatality. The underestimation was minimal below age 15 (about 2%) and larger at age 15-44 (about 1 l'%o). Due to the low sex ratios of the incidence at older ages, the excess female risk in case fatality persisted beyond age 45, although it was less pronounced than at age 15-44 (+27.7%).
DISCUSSION
This study was primarily based on the registration of deaths at the national level and on the declaration of deaths by cause. In most of the developedcountries death registration is virtually complete. In the developing countries used for this analysis, the completeness of death registration is well above 75% (this would not be true in many other developing countries). Measles is one of the easiest infectious diseases to diagnose, one of the most well-known by physicians throughout the world, and one of the most frequently studied infectious diseases. Measles usually comes in major epidemics, easily recognized even by the population. It is unlikely that a large number of measles deaths were ignored by the physicians in charge of assessing the causes of death. Therefore, the quality of the assessment of measles deaths depends primarily on the criteriaused for defining a death from measles. In fact, most deaths attributable to measles as the underlying cause are due to other infectious diseases as the immediate cause of death e.g. pneumonia, diarrhoea, encephalitis or other conditions. The International Classification of Diseases and Causes of Death provides clear guidelines to classify deaths by cause. If these were followed, one could expect a reasonable assessment of measles as a cause of death. However, the extent to which those guidelines are properly followed in cause of death statistics throughout the world remainsunclear. It is possible that themeasles death rates were underestimated because of misclassification of causes of death. In this study however, the use of data on the causes of death from various countries of the world to investigate sex differences did not require either completeness of registration of measles deaths or perfect assessment of deaths by cause. It required only the absence of systematic biases according to sex. There are several indications that this condition was fulfilled. First, the pattern of sex differences by age existed in.most countries, in all continents and in various cultural environments, including in the countries where the registration of measles cases and measles deaths was the most complete and the most reliable. Second, if there were biases, they would most likely have been in the opposite direction, that is towards an underregistration of female deaths. And third, in places where the underregistration of female deaths could have been expected, the highest excess female mortality was found.
Most of the measles deaths were concentrated in the O 4 age group. In this age group the relative risk of females was usually slightly above 100 but virtually always higher than that expected from all causes of death. In model life tables, this occurs only in the South-Asian model of the United Nations system for developing countries when life expectancy is lower than 60 years. This can be considered as one more piece of evidence that the pattern observed for measles is an outstanding one.
Excess female mortality at age 5-14 is more frequent in model life tables, At high levels of mortality, i.e. when life expectancy is lower than 50 years, this is a general effect found in virtually all regional patterns, with the exception of the Far-East Asian pattern. However, this is no longer the case when life expectancy exceeds 60 years, as in most of the countries considered for this analysis.
When life expectancy is greater than 40 years, excess female mortality at age 15-44 is found only in the SouthAsian pattern. However, this excess seems to disappear when life expectancy becomes higher than 60 years. At older ages, female mortality is usually consistently lower than male mortality, even at high levels of mortality in all the regional patterns.
It is hard to imagine that a pattern found so consistently throughout the world is due to behavioural factors, such as the differential management of the disease according to sex. Another type of explanation could be sought in differential exposure to the disease. Since no major differences were found in incidence, one could argue only that the intensity of exposure might differ between males and females. It is possible that personal contacts between index and secondary cases differ between boys and girls or between men and women. For instance, women such as nurses working in hospitals may be more at risk than men. However, if this was a general pattern, it should be true for most communicable diseases and therefore for all causes of death combined as well. Only a few communicable diseases, such as whooping cough, seem to exhibit a similar pattern of excess female mortality. All the others go in the opposite direction (a formal study of this pattern is currently underway by the same author). Another argument against the differential exposure hypothesis comes from the study in the rural area of Senegal, where intensity of exposure has been found to be a risk factor of measles m0rta1ity.l~ However, the FSR observed for measles mortality are higher than the risk ratios observed for childrenintensely exposed in a rural area of Senegal, one of the most severe environments for measles. It is not possible that all females, but none of the males, contracting measles were intensely exposed. In particular, this is the case for the age group 5-14, where most measles cases are contracted in school, where conditions are similar for both boys and girls. For those who were infected at home, the mean intensity of exposure was virtually the same for boys and girls in Senegal (2.98 for boys, 3.02 for girls), whereas the excess female mortality was 50%.
The age pattern of sex differences in measles mortality does not support a genetic origin. If females are at a genetic disadvantage for this disease, it would be consistent throughout life. Therefore, the most plausible hypothesis is a biological difference. There are many mechanisms through which differences between male and female could affect differences in measles mortality. For instance, a possible candidate is the effect of female steroids on the immune system. The level of estradiol peaks markedly during the female reproductive period, as does the excess female mortality. It is especially high during pregnancy. Measles has been found to be particularly severe during pregnancy. l6 Also, recent indications show that high levels of female hormones have a negative effect on cellular i m m~n i t y .~ In turn, cellular immunity, in particular T cells, monocytes and macrophages, plays amajor role in the control of measles infection. If this hypothesis supports the major peak observed at age 15-44, it seems unlikely to explain sex differences before age 15 years since the level of female hormones remains relatively low between age 3 months and puberty. However, little is known about sex differences in levels of female hormones in this age group and even less about their biological significance. This hypothesis of a role for female hormones remains speculative.
The different pattern of sex differences found in Thailand and the Philippines remains puzzling. Although it may well be due to random fluctuations. or to poor data, the geographical proximity of these two countries suggests that more research is needed. In particular, one could search for risk factors of measles mortality associated with males or for different patterns of female hormones in those populations.
The statistical procedure used in this analysis does not account for possible heterogeneity in the sex differences throughout the world. There was evidence of some heterogeneity besides the normal random fluctuations in the distribution of sex ratios in the countries with at least 300 measles deaths: 29% of them were significantly different from the mean, whereas as only 5% were expected in the homogeneous case. However, the sex ratios were normally distributed around the mean &' = 0.17, P = 0.99).
When heterogeneity is relatively small and normally distributed, the variance of the estimates is only increased by a few per cent. Most of the tests used here will still be valid even if the variance was increased by say 20%.
The reasons why the excess female mortality from measles has not been reported earlier probably derives from the lack of statistical power of annual national data. Given the small value of the sex differences in the age group where most deaths occurred, the pooling of many countries and years was required to achieve the demonstration. Only the proof by statistical power, which includes many instances of differences which are not significant due to the small number of measles deaths, could indicate that this phenomenon is most likely a general pattern.
The magnitude ofthe differencesmay seem to be small and of little relevance for public health purposes. However, the magnitude of the differences is significant for scientific purposes, and calls for more research. An observed 5% higher mortality-when a 25% lower mortality was expected-cannot be ignored. 
